MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on March 28, 2007; DOI: 10.1124/mol.106.032144


This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.106.032144v1
72/1/8    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Niesler, B.
Right arrow Articles by Bruess, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Niesler, B.
Right arrow Articles by Bruess, M.


Received for publication October 24, 2006.
Revised March 27, 2007.
Accepted for publication March 28, 2007.

Characterization of the Novel Human Serotonin Receptor Subunits 5-HT3C, 5- HT3D and 5-HT3E

Beate Niesler 1*, Jutta Walstab 2, Sandra Combrink 2, Dorothee Moeller 1, Johannes Kapeller 1, Jens Rietdorf 3, Heinz Boenisch 2, Manfred Goethert 2, Gudrun Rappold 1, Michael Bruess 2

1 Department of Human Molecular Genetics, University of Heidelberg 2 Institute of Pharmacology and Toxicology, University of Bonn 3 European Molecular Biology Laboratory

* Address correspondence to: E-mail: beate.niesler{at}med.uni-heidelberg.de

Abstract

Within the family of serotonin receptors, the 5-HT3 receptor is the only ligand-gated ion channel. It is composed of five subunits, of which the 5-HT3A and 5-HT3B subunits are best characterized. Several studies, however, have reported on the functional diversity of native 5-HT3 receptors which cannot solely be explained on the basis of the 5-HT3A and 5-HT3B subunits. Following our discovery of further putative 5-HT3 serotonin receptor encoding genes, HTR3C, HTR3D and HTR3E, we investigated wether these novel candidates and the isoform 5-HT3Ea are able to form functional 5-HT3 receptor complexes. Using immunofluorescence and immunoprecipitation studies of heterologous expressed proteins, we found that each of the respective candidates co-assembles with 5-HT3A. To investigate if the novel subunits modulate 5-HT3 receptor function, we performed radioligand-binding assays and calcium-influx studies in HEK293 cells. Our experiments revealed that the 5-HT3C, D, E and Ea subunit alone cannot form functional receptors. Co-expression with 5-HT3A, however, result in the formation of functional heteromeric complexes with different serotonin efficacies. Potencies of two agonists and antagonists were nearly identical with respect to homomeric 5-HT3A and heteromeric complexes. However, 5-HT showed increased efficacy with respect to 5-HT3A/D and 5-HT3A/E receptors, which is consistent with the increased surface expression compared to 5-HT3A receptors. In contrast, 5-HT3A/C and 5-HT3A/Ea receptors exhibited decreased 5-HT efficacy. This data shows for the first time that the novel 5-HT3 subunits are able to form heteromeric 5-HT3 receptors which exhibit quantitatively different functional properties compared to homomeric 5-HT3A receptors.


Key words: Serotonin, Serotonin, Func. analysis receptor/ion channel mutants, Immunocytochemistry, Receptor binding studies


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
J. Kapeller, L. A. Houghton, H. Monnikes, J. Walstab, D. Moller, H. Bonisch, B. Burwinkel, F. Autschbach, B. Funke, F. Lasitschka, et al.
First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome
Hum. Mol. Genet., October 1, 2008; 17(19): 2967 - 2977.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
Y. Noam, W. J. Wadman, and J. A. van Hooft
On the voltage-dependent Ca2+ block of serotonin 5-HT3 receptors: a critical role of intracellular phosphates
J. Physiol., August 1, 2008; 586(15): 3629 - 3638.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. R. Livesey, M. A. Cooper, T. Z. Deeb, J. E. Carland, J. Kozuska, Tim. G. Hales, J. J. Lambert, and J. A. Peters
Structural Determinants of Ca2+ Permeability and Conduction in the Human 5-Hydroxytryptamine Type 3A Receptor
J. Biol. Chem., July 11, 2008; 283(28): 19301 - 19313.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Krzywkowski, P. A. Davies, P. L. Feinberg-Zadek, H. Brauner-Osborne, and A. A. Jensen
High-frequency HTR3B variant associated with major depression dramatically augments the signaling of the human 5-HT3AB receptor
PNAS, January 15, 2008; 105(2): 722 - 727.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
K. B. Fink and M. Gothert
5-HT Receptor Regulation of Neurotransmitter Release
Pharmacol. Rev., December 1, 2007; 59(4): 360 - 417.
[Abstract] [Full Text] [PDF]


Home page
Mol Biol EvolHome page
A. M. Andres, C. de Hemptinne, and J. Bertranpetit
Heterogeneous Rate of Protein Evolution in Serotonin Genes
Mol. Biol. Evol., December 1, 2007; 24(12): 2707 - 2715.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics